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Abstract: Hyperthyroidism increases the vulnerability of the heart to ischemia-reperfusion (I/R) injury. Regarding the
fact that diazepam also affects cardiac I/R injury, the current study was conducted to investigate the effect of diazepam on
ischemia-reperfused isolated hyperthyroid rat heart. The animals were divided into 6 groups: the control, hyperthyroid,
control diazepam (1 mg/kg), hyperthyroid diazepam (1 mg/kg), control diazepam (5 mg/kg), and hyperthyroid
diazepam (5 mg/kg) groups. Langendorff-perfused rat hearts underwent 40 min of global ischemia and 45 min of
reperfusion. Different cardiac parameters, including the left ventricular developed pressure, heart rate, coronary flow,
and rate pressure product (RPP), were measured. Lactate dehydrogenase (LDH) release was determined in reperfusion
to evaluate the severity of the myocardial injury. The results showed that the RPP recovery percentage significantly
decreased in the hyperthyroid group compared with control group, whereas comparison of the hyperthyroid diazepam
(1 mg/kg) with the control and control diazepam (1 mg/kg) groups did not reveal a significant difference. These results
were confirmed by LDH test, demonstrating that administration of diazepam (1 mg/kg) protected the heart against I/R
injury in the hyperthyroid group and significantly decreased the I/R injury, which was probably due to the function of
diazepam as a phosphodiesterase 4 inhibitor.
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Introduction
Normal heart structure and function are dependent
on normal thyroid hormone levels (1). Changes
in thyroid hormone levels alter the vulnerability
of the heart against ischemia-reperfusion (I/R)
injury (2). For instance, it has been found that
in hyperthyroidism, the susceptibility of the
myocardium to I/R injury increases due to
mitochondrial respiration dysfunction (2), H2O2
production, and higher oxidative damage (3).
Furthermore, thyroid hormone can affect peripheral
benzodiazepine receptor (PBR) density (4).
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The PBR is an 18-kDa protein, consisting of 169
amino acids and located in the outer mitochondrial
membrane (5). It has been suggested that PBRs are
involved in several processes, including the regulation
of the opening of the mitochondrial permeability
transition pore (MPTP), cell necrosis (6,7), apoptosis,
respiratory chain, and ion channel activity (8,9).
Meanwhile, cellular resistance to oxidative stress has
been shown to be related to the expression of these
receptors in cells (10).
It has been shown that chronic diazepam
administration regulates PBR density in the peripheral
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organs (11). For example, it was demonstrated
that a 14-day diazepam administration produced
upregulation of heart PBR density (12). Therefore,
cardiac resistance to I/R injury might be affected by
chronic diazepam administration. The protective
effects of diazepam have also been reported (13). For
example, it was indicated that diazepam, as a selective
type-4 phosphodiesterase inhibitor, leads to cyclic
adenosine monophosphate (cAMP) enhancement
in cardiac tissue (14). In vitro and in vivo studies
have demonstrated that an increase of cAMP inhibits
apoptosis in cardiomyocytes and reduces mortality in
acute myocardial infarction (13). Moreover, studies
have shown that diazepam is able to affect cells by
paths related (8) or unrelated (15) to PBR.
According to the dual effects of diazepam on cells,
it is not clear how it can affect the hyperthyroid heart
during I/R. This is a point that has not been reported
in previous studies. Therefore, regarding the positive
and negative effects of diazepam on I/R injury and
the common clinical use of benzodiazepines, the
current study was conducted to investigate effects
of diazepam on ischemia-reperfused isolated
hyperthyroid rat heart.
Materials and methods
Materials
All of the chemicals (Merck, Darmstadt, Germany)
were of the highest grades available. Lactate
dehydrogenase (LDH) was assessed using a cell
cytotoxicity kit (Roche, Mannheim, Germany).
L-thyroxine (T4) was purchased from Sigma
(Steinheim, Germany) and the diazepam was from
the Chemi Daru Company (Iran, Tehran).
Animals and their treatments
This investigation was approved by the ethics
committee of the Kermanshah University of Medical
Sciences. All of the animals used in the present
study received humane care in compliance with the
institutional animal care guidelines. Male Wistar
rats (250-300 g) were obtained from the animal care
center at the Kermanshah University of Medical
Sciences. They were maintained under standard
laboratory conditions (controlled temperature of 21
°C, 12-h light/dark cycle).

The animals were divided into 6 groups, as follows.
1. General control group (n = 8): This group was
fed normal rat pellet and normal water, and
had an intraperitoneal (IP) injection of normal
saline (sodium chloride) for 5 days.
2. Hyperthyroidism group (n = 8): In this group,
hyperthyroidism was induced by adding T4
(Sigma, catalog number T-2376; 12 mg/L) to
the drinking water for 21 days (16), and the
animals also had an IP injection of normal
saline during the last 5 days of the treatment.
3. Control diazepam (1 mg/kg)-administered
group (n = 8): This group received the same
treatment as group 1, but received a daily IP
injection of 1 mg/kg diazepam for 5 days.
4. Hyperthyroidism diazepam (1 mg/kg)administered group (n = 8): This group received
the same treatment as group 2, but received a
daily IP injection of 1 mg/kg diazepam during
the last 5 days of treatment.
5. Control diazepam (5 mg/kg)-administered
group (n = 9): This group received the same
treatment as group 1, but received a daily IP
injection of 5 mg/kg diazepam for 5 days.
6. Hyperthyroidism diazepam (1 mg/kg)administered group (n = 10): This group
received the same treatment as group 2,
but received a daily IP injection of 5 mg/kg
diazepam during the last 5 days of treatment.
Thyroid hormone concentration
The animals were randomly selected, and after
anesthesia, blood samples were collected from the
abdominal aorta, placed in tubes, and immediately
centrifuged at 1500 rpm for 5 min. The serum thyroid
hormone concentration was then estimated using the
radioimmunoassay method (17).
Isolated heart preparation
Isolated rat hearts were perfused at a constant
hydrostatic pressure according to the Langendorff
technique (18,19). The rats were anesthetized with an
IP administration of 60 mg/kg pentobarbital sodium
(Sigma). The hearts were rapidly excised, placed
in ice-cold Krebs buffer (4 °C), rapidly cannulated
and retrogradely perfused through the aorta in a
noncirculating Langendorff apparatus (Harvard
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Apparatus Ltd., Edenbridge, UK) with Krebs solution
[containing sodium chloride (118 mmol/L), sodium
bicarbonate (25 mmol/L), potassium chloride (4.8
mmol/L), potassium dihydrogen phosphate (1.2
mmol/L), magnesium sulfate (1.2 mmol/L), glucose
(11 mmol/L), and calcium chloride (1.2 mmol/L)]
at pH 7.4. The Krebs solution was filtered through
Whatman paper No. 1002-125 and then bubbled
with 95% oxygen and 5% carbon dioxide at 37 °C,
and perfusion was performed under a constant
hydrostatic pressure of 65 mmHg. Following the
removal of the left atrial appendage, a deflated
water-filled latex balloon was inserted through the
mitral valve into the left ventricle. This balloon was
connected via a rigid polyethylene tube to a pressure
transducer (MLT 844; AD Instruments, New South
Wales, Australia), which in turn was connected via
an ML110 BP amp (AD Instruments), an ML825
Power Lab 2.25 (AD Instruments) system, and Chart
5 software (AD Instruments) to a computer for
continuous monitoring of cardiac performance. At
the beginning of the experiment, the balloon volume
was adjusted to achieve a stable end diastolic pressure
of 5-10 mmHg. This volume was then kept constant
for the duration of the study. Different indices of
myocardial function were assessed, including left
ventricular developed pressure (LVDP, in mmHg),
which was defined as the peak systolic pressure
minus the end diastolic pressure, and heart rate (HR,
in beats per minute). The rate pressure product (RPP)
was calculated as: RPP = LVDP × HR. Coronary flow
(CF) was measured by timed volumetric collection of
the coronary effluent. The baseline data were recorded
after a 20-min stabilization and equilibration period.
Global normothermic ischemia was induced by
clamping the aortic cannula. The temperature was
maintained by immersing the heart in perfusion
medium at 37 °C. The hearts were subjected to global
ischemia for 40 min, followed by reperfusion for 45
min.

was collected at the first minute of reperfusion. The
samples were measured using a cell cytotoxicity
detection kit (LDH, Roche) and known quantities of
LDH (Sigma) as a standard.
Statistical analysis
Data were expressed as mean ± standard error of the
mean (SEM) and were compared using the unpaired
Student’s t-test as appropriate or ANOVA and Tukey’s
posttest, as offered by GraphPad InStat version 3.0
(GraphPad Software Inc., La Jolla, CA, USA). P <
0.05 was considered significant.
Results
Thyroid state
The thyroid state of different groups of animals
was characterized by the data reported in Table 1.
The values indicate a significant rise in T3 after oral
L-thyroxine administration (P = 0.004).
Hemodynamic function
The data for HR, LVDP, CF, and RPP at different
periods of the experiment are summarized in Table
2. HR, CF, and RPP during the baseline period
were higher (P < 0.05) in the hyperthyroid and
hyperthyroid diazepam (5 mg/kg)-administered
groups compared with their related controls. The
LVDP and RPP at minute 45 of reperfusion in the
hyperthyroid and hyperthyroid diazepam (5 mg/kg)administered groups were lower than in the related
control groups (P < 0.05).
Cardiac functional recovery percentage
The recovery percentage at minute 45 of reperfusion
in the hyperthyroid group (18 ± 1.5%) was
significantly lower (P < 0.01) than in the control
group (43 ± 3.1%), and there was also a significant
Table 1. Comparison of the thyroid function test. Value was
expressed as mean ± SEM.

LDH assessment
When cells die, they release their intercellular LDH.
Measuring this activity in the resulting supernatant
reveals the extent of cell death. Therefore, the level
of I/R injury was assessed based on the functional
recovery and the release of LDH into the effluent.
In order to measure the LDH, coronary effluent
600

Groups

T3 (nmol/L)

Control (n = 6)

0.72 ± 0.048

Hyperthyroid (n = 6)

0.93 ± 0.029*

*P = 0.004 versus control (unpaired t-test).
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Table 2. Cardiac parameters before and after exposure to 40 min of global normothermic ischemia in the groups.
Baseline values
RPP
CF
(mmHg × beats/
(mL/min)
min)

LVDP
(mmHg)

HR
(beats/min)

CF
(mL/min)

RPP
(mmHg ×
beats/min)

19666 ± 640

34.88 ± 2.7

247 ± 6

5.65 ± 0.57

8503 ± 475

275.75 ± 8* 11.75 ± 0.28* 22148 ± 960*

23.95 ± 4.1*

220 ± 37

4.68 ± 0.33

4007 ± 258*

21913 ± 1102

35.22 ± 7.13

252 ± 14

6.45 ± 0.47

9862 ± 1337

12.43 ± 0.53

22386 ± 1194

32.15 ± 4.7

285 ± 16

7.17 ± 0.61

8877 ± 1117

9.3 ± 0.61

18295 ± 1102

36 ± 5.1

199 ± 39

5.7 ± 0.6

6047 ± 829

217 ± 21

7.64 ± 1.2

3684 ± 658#

Groups

LVDP
(mmHg)

HR
(beats/min)

Control

80.20 ± 3

247 ± 6

Hyperthyroid

78.8 ± 4

Control
diazepam
(1 mg/kg)

84.35 ± 5

263 ± 16

12.12 ± 0.50

Hyperthyroid
diazepam
80.41 ± 5
(1 mg/kg)

267 ± 15

89.9 ± 4.7

208 ± 15

Hyperthyroid
diazepam
81.56 ± 3
(5 mg/kg)

254 ± 6#

Control
diazepam
(5 mg/kg)

45 min of reperfusion

10.3 ± 0.58

13.15 ± 0.86# 21639 ± 826# 17.31 ± 2.77#

LVDP: left ventricular developed pressure (mmHg), HR: heart rate (beats/min), CF: coronary flow (mL/min), RPP: rate pressure product
(LVDP × HR). Data were analyzed using unpaired t-test and expressed as mean ± SEM between the test and related control groups. The
groups include: control (n = 8), hyperthyroid (n = 8), control diazepam (1 mg/kg)-administered (n = 8), hyperthyroid diazepam (1 mg/
kg)-administered (n = 8), control diazepam (5 mg/kg)-administered (n = 9), and hyperthyroid diazepam (5 mg/kg)-administered (n
= 10). *P < 0.05 versus the control group and #P < 0.05 versus the control diazepam (5 mg/kg)-administered group (unpaired t-test).

difference between the control diazepam (5 mg/
kg)-administered group (33 ± 4.2%) and the
hyperthyroid diazepam (5 mg/kg)-administered
group (17 ± 3%) (P < 0.05). However, there was no
significant difference between the hyperthyroid
diazepam (1 mg/kg)-administered group (40 ± 5.3%)
and either the related control group (45.3 ± 5.5%) or
the general control group (43 ± 3.1%). The recovery
percentage in the hyperthyroid diazepam (1 mg/kg)administered group (40 ± 5.3%) was significantly
higher (P < 0.01) than in the hyperthyroid group (18
± 1.5%). Moreover, there was a significant difference
between the control and hyperthyroid diazepam (5
mg/kg)-administered groups (P < 0.001) (Figure 1).
Lactate dehydrogenase release
The extent of reperfusion injury in the 6 groups
was determined based on the release of a marker
intracellular enzyme into the effluent. The
concentration of released LDH during the first minute

of reperfusion from the hearts in the hyperthyroid
group (41 ± 8.14 mU/mL) was significantly higher
than that of the control group (11.45 ± 6.25 mU/mL)
(P < 0.01); there was no significant difference between
the hyperthyroid diazepam (1 mg/kg)-administered
group (20.28 ± 4.16 mU/mL) and either the related
control group (12.86 ± 0.32 mU/mL) or the general
control group (11.45 ± 6.25 mU/mL). There was a
significant difference between the control diazepam
(5 mg/kg)-administered group (37.2 ± 1.02 mU/
mL) and the hyperthyroid diazepam (5 mg/kg)administered group (57.95 ± 1.55 mU/mL) (P <
0.05). The LDH in the hyperthyroid diazepam (1
mg/kg)-administered group (20.28 ± 4.16 mU/mL)
was significantly lower than that in the hyperthyroid
group (P < 0.05). Levels of LDH in the hyperthyroid
diazepam (5 mg/kg)-administered group (57 ± 1.55
mU/mL) were significantly higher than those of the
hyperthyroid diazepam (1 mg/kg)-administered
group (P < 0.001).
601

Cardioprotective effect of diazepam on ischemia-reperfused isolated hyperthyroid rat heart

Discussion
The results of the current study demonstrate that
diazepam modulates hyperthyroidism effects.
These new findings are indicative of the effects of
benzodiazepine on changes of heart activity caused
by hyperthyroidism. As illustrated in Table 2, chronic
diazepam (1 mg/kg) administration to hyperthyroid
rats led to protection against I/R injury in the heart.
Moreover, the exacerbated I/R injury that occurred
in the hyperthyroid group was not seen in the
hyperthyroid diazepam (1 mg/kg) group (Figure
1). This finding was also confirmed by LDH results
(Figure 2). In fact, compared with the hyperthyroid
group, the significant reduction of released LDH in
the hyperthyroid animals that received diazepam
(1 mg/kg) represents decreased I/R injury in this
group. As illustrated in Figure 1, in the hyperthyroid

group, cardiac functional recovery following I/R was
significantly lower than that of the control group.
This finding was confirmed by the LDH results,
which are presented in Figure 2. The increase in
concentration of released LDH in the first minutes
of reperfusion in the hyperthyroid group versus
the control indicates further damage to the heart
during the I/R period. This observation confirms
previous reports indicating higher susceptibility of
the hyperthyroid rat heart to I/R (2,20,21). Previous
studies have revealed that mitochondrial function
is impaired in hyperthyroidism due to the excessive
production of reactive oxygen species, dysfunction of
mitochondrial respiration at stage 3 (3), and increased
H2O2 production (2). Moreover, it was reported that
chronic thyroxine administration gives rise to rat
PBR density (4). Enhancement of PBR density leads

80
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Figure 1. Recovery percentage (in comparison with the baseline)
of the RPP at 45 min of reperfusion following 40 min
of global normothermic ischemia in the control group
(n = 8), hyperthyroid group (n = 8), control diazepam
(1 mg/kg)-administered group (n = 8), hyperthyroid
diazepam (1 mg/kg)-administered group (n = 8),
control diazepam (5 mg/kg)-administered group
(n = 9), and hyperthyroid diazepam (5 mg/kg)administered group (n = 10). Data are expressed as
mean ± SEM with ANOVA. **P < 0.01 versus the
hyperthyroid diazepam (1 mg/kg)-administered
group. $$P < 0.01 versus the hyperthyroid diazepam (5
mg/kg)-administered group.
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Figure 2. The concentration of LDH enzyme (mU/mL) that
was released during the first minute of reperfusion
following 40 min of global normothermic ischemia in
the control group (n = 8), hyperthyroid group (n = 8),
control diazepam (1 mg/kg)-administered group (n= 8),
hyperthyroid diazepam (1 mg/kg)-administered group
(n = 8), control diazepam (5 mg/kg)-administered
group (n = 9), and hyperthyroid diazepam (5 mg/
kg)-administered group (n = 10). Data are expressed
as mean ± SEM with ANOVA. *P < 0.05 versus the
hyperthyroid diazepam (1 mg/kg)-administered group.
***P < 0.001 versus the hyperthyroid diazepam (5 mg/
kg)-administered group.
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to an increase in the intramitochondrial calcium
of cardiomyocytes, which in turn increases MPTPs
(22), mitochondrial dysfunction, and, consequently,
cell death (23). Therefore, the exacerbated I/R injury
in the hyperthyroid group can be justified by these
mechanisms. In addition, the findings of the present
study indicate cardiac protection in the hyperthyroid
diazepam (1 mg/kg) group. Other studies have
demonstrated that chronic diazepam administration
can alter the vulnerability of cardiac I/R injury by the
enhancement of PBR density (24). The enhancement
of PBR density also occurs in hyperthyroidism (4).
Therefore, it is expected that diazepam would lead to
negative effects in the hyperthyroid heart during I/R.
However, the findings of the current study suggest
that diazepam not only improved heart function, but
also had a nonnegative effect and protected the heart
against I/R injury. Previous studies have reported that
diazepam acts as an inhibitor of phosphodiesterase 4
(25). Inhibition of this isoenzyme results in increased
cAMP levels (25), and thereby suppresses tumor
necrosis factor-alpha (TNF-α) (26). Furthermore,
the inhibition of phosphodiesterase results in
the blockage of TNF-α gene transcription and,
consequently, its protein production (27). The
reduction in TNF-α production could be regarded
as an important mechanism that protects the heart
against I/R injury (27). TNF-α is one of the cytokines
that may contribute to cell death by apoptosis, which
occurs during I/R injury (28). Moreover, it has been
observed that after chronic thyroxine administration,
TNF-α will increase (29). Thus, the exacerbation of
I/R injury may have been due to increased TNF-α in
the hyperthyroid group. It seems that in the current
study, diazepam (1 mg/kg) was able to affect heart
function through the inhibition of phosphodiesterase
type 4, the enhancement of cAMP, and, subsequently,
the reduction of TNF-α. Therefore, the protective
effect of diazepam in the hyperthyroid heart may be
explained by this mechanism. However, the exact
role of this mechanism remains to be elucidated in
future studies.
Another valuable finding of the current study was
the modulation of heart function in the hyperthyroid
group after diazepam (1 mg/kg) administration.

As illustrated in Table 2, there was a significant
difference between the baseline heart rate in the
hyperthyroid group and its related control group.
This difference was not seen, however, after diazepam
(1 mg/kg) administration. It has been reported that
hyperthyroidism increases the heart rate via several
mechanisms, such as increased L-type calcium
channels (30,31), activity of Ca+2 ATPase (32),
alpha-myosin heavy chain gene expression (31), and
decreased phospholamban (33). The chronotropic
effect of hyperthyroidism was eliminated after
diazepam (1 mg/kg) administration, which represents
the modulatory effects of diazepam (1 mg/kg) on
heart function. Further studies are required to reveal
the cellular mechanism of diazepam on the heart rate
of hyperthyroid rats.
The cardioprotective effect of diazepam (1 mg/kg)
was not seen after the administration of diazepam
(5 mg/kg) in the hyperthyroid group. Moreover, the
heart rate in the hyperthyroid diazepam (5 mg/kg)
group was significantly higher than that of its related
control group (Table 2).
Exacerbated I/R injury was seen in the
hyperthyroid diazepam (5 mg/kg) group compared
with the related control groups, as was the case for
the hyperthyroid group compared with its related
control groups. In addition, the enhancement of
released LDH in these groups confirmed I/R injury
(Figure 2). In fact, diazepam (5 mg/kg) cannot protect
from exacerbated I/R injury. The negative effects of
diazepam (5 mg/kg) were shown in a previous study
(11). Dose-dependent effects of benzodiazepines
have also been reported (34). For example, previous
studies demonstrated that PBR ligands could induce
MPTP opening in a dose-dependent manner (34).
Therefore, the protective effect of diazepam is limited
to a dosage of 1 mg/kg. Overall, the findings of
the current study reveal that diazepam modulates
hyperthyroid cardiac function; these effects are dosedependent and are seen at 1 mg/kg.
The current study showed that administration
of diazepam (1 mg/kg) significantly reduced the
exacerbated I/R injury in the hyperthyroid group.
This effect was probably due to the effect of diazepam
as an inhibitor of phosphodiesterase 4.
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